←Back to Expert Scholars
Translational Medicine / 转化医学Lung Oncogenic Fusions
Andrea Varga
MD, PhD
🏢Gustave Roussy🌐France
Medical Oncologist
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Andrea Varga leads early-phase trials at Gustave Roussy enrolling patients with rare fusion oncogenes. Her work contributed to NTRK and other fusion-directed registrational studies. She co-authors European guidelines for tumor-agnostic fusion therapy.
Share:
🧪Research Fields 研究领域
Early-phase trials
Rare fusions
NTRK therapy
European oncology
Biomarker-selected trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Andrea Varga 的研究动态
Follow Andrea Varga's research updates
留下邮箱，当我们发布与 Andrea Varga（Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment